A Review of Percutaneous Transluminal Angioplasty in Hemodialysis Fistula.
A Review of Percutaneous Transluminal Angioplasty in Hemodialysis Fistula. Int J Vasc Med. 2018;2018:1420136 Authors: Bountouris I, Kritikou G, Degermetzoglou N, Avgerinos KI Abstract The number of patients in dialysis increases every year. In this review, we will evaluate the role of percutaneous transluminal angioplasty (PTA) according to patency of arteriovenous fistula and grafts. The main indication of PΤΑ is stenosis> 50% or obstruction of the vascular lumen of an arteriovenous fistula and graft. It is usually performed under local anesthesia. The infection rate is as low as the number of complications. Fistula can be used in dialysis in the same day without the need for a central venous catheter. Primary patency is>50% in the first year while primary assisted patency is 80-90% in the same time period. Repeated PTA is as durable as the primary PTA. An early PTA carries a risk of new interventions. Cutting balloon can be used as a second-line method. Stents and covered stents are kept for the management of complications and central outflow venous stenosis. PTA is the treatment of choice for stenosis or obstruction of dialysis fistulas. Repeated PTA may be needed for better patency. Drug eluting balloon may become the future in PTA of dialysis fistula, but more trials are needed. PMID: 29785307 [PubMed]
Abstract OBJECTIVE: Using a feasibility analysis and matched subgroup analysis, this study investigated the implementation/safety/outcomes of a stroke recovery program (SRP) integrating modified cardiac rehabilitation for stroke survivors. DESIGN: This prospective cohort study of 783 stroke survivors were discharged from an inpatient rehabilitation facility to an outpatient setting; 136 SRP-participants completed a feasibility study and received the SRP including modified cardiac rehabilitation, 473 chose standard of care rehabilitation (nonparticipants), and a group (n = 174) were excluded. The feasibility s...
Publication date: Available online 21 October 2019Source: Best Practice &Research Clinical AnaesthesiologyAuthor(s): Girish P. Joshi, Francis Bonnet
ConclusionsThis case series demonstrates that the use of a high frequency jet ventilator for cardiac MRI was feasible, safe, providing good quality cardiac imaging and avoiding anesthesia personnel to be inside the hazardous environment of MRI room. Future studies are needed to confirm its safety and efficiency in pediatric patients.ResumoJustificativa e objetivosA ressonância magnética (RM) cardíaca é uma técnica utilizada na avaliação de crianças com cardiopatias congênitas. A anestesia geral garante imobilidade, especialmente em pacientes não cooperador...
This article focuses on the functional features of positive-pressure ventilators, the modes of invasive and non-invasive mechanical ventilation, and the main ventilator settings. It also highlights the potential complications of mechanical ventilation, the basic principles of weaning, and the pathophysiological basis of patient-ventilator dyssynchrony.
In conclusion, this review reported that IL-37 has a crucial role in reducing infection-associated inflammation and has a good impact on inflammation-induced pathology. However, tight regulation that achieved balance between effector immune responses that required for pathogen elimination and limited tissue damage that resulted from excessive inflammation should be existed in the potential IL-37 therapy to prevent clinical complications of a disease. PMID: 31633447 [PubMed - as supplied by publisher]
Date: Monday, 10 21, 2019; Speaker: See attached agenda; Building 10; Masur (10/21/19) and Lipsett (10/22/19)
Date: Wednesday, 10 23, 2019; Speaker: Joseph Zaia, Ph. D., Boston University; Building 50; 1227/1233; Videocast Event
Date: Thursday, 10 24, 2019; Speaker: Bruce Tromberg, NIBIB Director, NIBIB/ NIH; Dr. Susan Gregurick, Associate Director for Data Science, NIH; Building: Building 45 (Natcher Building); Videocast Event
Date: Thursday, 10 24, 2019; Speaker: Joachim Lingner, Ph.D., Full Professor for Life Sciences, EPF Lausanne (Swiss Federal Institute of Technology); Building: Building 37; Conference Room 6041/6107
Date: Monday, 10 28, 2019; Speaker: Xiangbo Ruan, Regulation of systemic lipid metabolism by human lncRNAs, The Cao group, CB, NHLBI; Ranganath Muniyappa, Hyperuricemia in insulin resistance, DEOB, NIDDK; Building: Building 10 (Clinical Center); Solarium Conference Room 9S233 (old Bunim Room)